The number one way to learn about the market
Investing doesn't have to be as hard as you think. With one email a day, you'll learn everything you need to know to make better choices with your money. See how over a million people are taking control of their wealth.
Proudly Featured In
Learn from the experts
Tap into our network of experienced analysts. From former hedge fund managers, multi-billion-dollar pension fund managers, advisors, traders, professors, accountants, financial lawyers, inventors and doctors, there's not a corner of the market we can't help you understand.
Our team will show you the best ways to protect and grow your money no matter what's happening in the market. We'll be with you every step of the way regardless of your starting point, your risk tolerance or your financial interests. You're guaranteed to find something you like.
Subscribers Worldwide
1M+
Editors & Analysts
33
No. of Products
31
No. of 10x Recommendations
24
Find what works for you
Whether you're just starting out or a seasoned professional, there's something for everyone. Each one of our 30+ research services are designed to protect and grow your wealth.
Join the 1M+ people growing their wealth with Stansberry Research
Given me an edge
Stansberry Research has given me an edge in facing the ever-changing times we are in - not everyone has found it as easy. Thank you, you do a great job.
Mervyn D.
Subscriber since 2013
Cashed out with about a 500% gain
We recently cashed out with about a 500% gain. You do good work. We're a retired couple, on a fixed income, so getting the growth in the IRA is very helpful.
David B.
Subscriber since 2000
Broadened my knowledge
Stansberry Research has broadened my knowledge in so many areas, including options and short sales that I never imagined I'd do. The recommended investments are so comprehensive, I love it!
Laura P.
Subscriber since 2015
I'm richer, smarter, and wiser
I have two degrees, an MBA, and PhD, and I have learned more about business and finance through Stansberry than all my degrees combined. I'm richer, smarter, and wiser today because of you.
Adriano R.
Subscriber since 2013
The means to achieve financial independence
I know the success I have had in the last three months, managing my own financial account and making gains during challenging times is due to the outstanding work and recommendations of Stansberry Research and the availability and support of the team. Partnering with Stansberry has given me the means to achieve financial independence.
Linda
Subscriber since 2020
Returns speak for themselves
I have been a member for years now and am a professional advisor, but I can't express my gratitude any more than looking at the returns I have generated this year by being an avid reader of all your newsletters. These returns speak for themselves. I can't thank you enough and feel honored to have found your services a few years back.
Pete C.
Subscriber since 2015
In the Stansberry Innovations Report, editor Eric Wade and our team of technology experts focus on the most pioneering and disruptive technologies around the world today.
The team looks for early opportunities in new technology trends that span the medical sciences, biotechnology, software, hardware, defense, and cryptocurrencies. These trends will likely play out over several years and decades.
Eric Wade
Editor
Largest Gain of Closed Position
446%
No. of 100%+ Winners
6
Model Portfolio Return vs S&P 500
+10.3%
Publication Overview
Publishing Schedule
Monthly (third Friday of every month) with email updates as needed
Required Capital
Approx. $1000 / Great for beginning investors, retirees, and those planning for retirement
Risk Tolerance
Conservative
Everything you need, all in one place
Nearly 1 in 2 Americans think they don't have enough money to enjoy retirement. We're changing the game. Sign up to get our best ideas every day the market's open.
Trending financial news
We watch the markets 24 hours a day, 365 days a year so you don't have to. Check out the latest issue of The Stansberry Digest, our flagship newsletter.
The Only Rule That Matters Right Now
What to do with mixed market signals... Control what you can control... Why we're not calling a bottom... One market gauge says 'don't buy yet'... Booking a 107% gain in four months... Good reasons to sell...
The wait is on...
Yesterday morning, President Donald Trump offered Iran (and the market) a public olive branch of sorts, with the idea of negotiating a "resolution" of the war.
Today, we saw skepticism about that thought. Oil prices were higher (by about 4%), bond yields rose (again), and the energy sector of the S&P 500 was up by about 2% (again).
Meanwhile, the major U.S. indexes were mixed after rising yesterday.
Notably, the benchmark S&P 500 Index lost 0.4% and remained below its 200-day moving average (200-DMA), a simple technical measure of a long-term trend, for a fourth stra
Keep reading with a free account
Get access to the full article, plus access to our entire archive when you enter your email below.
The Escape From Once-Beloved Tech Stocks Continues
Mar 25, 2026
Editor's note: Strong earnings don't always mean a rising stock price. When expectations are extremely high, even great results can disappoint investors. In this issue, Ethan Goldman of our corporate affiliate Chaikin Analytics explains why strong earnings led to a falling stock price for America's largest chip leader – and how the Chaikin team's system can help you spot these warning signs ahead of time.You likely know the four most dangerous words in investing...
Keep reading...
The Iran War's Invisible Threat
Mar 25, 2026
The financial market took a long, cautious breath on Monday...It exhaled just enough to push stocks 1% higher after a bruising few weeks.
Keep reading...
Episode 457: The Mag Seven Trade Is Breaking... Here's What Comes Next
Mar 24, 2026
In this week's Stansberry Investor Hour, Dan welcomes David Cervantes back to the show. David is the founder of Pinebrook Capital Management – a boutique asset manager focused on asset allocation and managing various systematic trading strategies.David kicks things off by reflecting on the progress that glucagon-like peptide-1 (GLP-1) drugs have made since his last discussion at a Stansberry Research Conference several years ago. The drug has branched out of medical use into professional use and for standard weight loss, resulting in the companies he previously discussed to have performed well since then. He then discusses the current market shift from the Magnificent Seven to industrials and the S&P 493. The equal-weighted S&P 500, in particular, is beginning to outperform the Mag Seven. And David shares his thoughts on Blue Owl Capital selling its assets and what that means for the private-equity industry...
Listen to the episode
I'm yawning at the current market turmoil; Thoughts on Meta Platforms' recent news – as both a citizen and an investor; A look at AMC Entertainment
Mar 25, 2026
1) The war in Iran has created turmoil in the markets...Oil prices have been volatile, spiking during the initial conflict but falling below $100 per barrel today with news of peace talks.
Keep reading...
